NDC 33332-318-01 Afluria Quadrivalent
Influenza A Virus A/singapore/gp1908/2015 Ivr-180a (h1n1) Antigen (propiolactone Inactivated), Influenza A Virus A/singapore/infimh-16-0019/2016 Ivr-186 (h3n2) Antigen (propiolactone Inactivated), Influenza B Virus B/maryland/15/2016 Antigen (propiolactone Inactivated), And Influenza B Virus B/phuket/3073/2013 Bvr-1b Antigen (propiolactone Inactivated)
NDC Package Code 33332-318-01
The NDC Code 33332-318-01 is assigned to Afluria Quadrivalent, a vaccine lable labeled by Seqirus Pty Ltd. The product's dosage form is injection, suspension and is administered via intramuscular form.
Code Structure
- 33332 - Seqirus Pty Ltd
- 33332-318 - Afluria Quadrivalent
- 33332-318-01 - 10 SYRINGE, GLASS in 1 CARTON
- 33332-318 - Afluria Quadrivalent
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the disclaimer below.
NDC HCPCS Crosswalk
This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.
NDC 33332-318-01 HCPCS crosswalk information with package details and bill units information.
NDC Billing Code | HCPCS Code | HCPCS Code Desc. | Dosage | Package Size | Package Quantity | Billable Units | Billable Units / Pkg |
---|---|---|---|---|---|---|---|
33332031801 | 90686 | IIV4 VACC NO PRSV 0.5 ML IM | 0.5 ML | 0.5 | 10 | 1 | 10 |
* Please review the disclaimer below.